​
​

Marinus Pharmaceuticals (MRNS) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Marinus Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$30.99M

Latest Revenue (Q)

$8.06M

Main Segment (Y)

Product revenue, net

Marinus Pharmaceuticals Revenue by Period

Marinus Pharmaceuticals Revenue by Year

DateRevenueChange
2023-12-31$30.99M21.63%
2022-12-31$25.48M66.03%
2021-12-31$15.35M793.19%
2020-12-31$1.72M100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31--100.00%
2012-12-31$100.00K-

Marinus Pharmaceuticals generated $30.99M in revenue during NA 2023, up 21.63% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Marinus Pharmaceuticals Revenue by Quarter

DateRevenueChange
2024-06-30$8.06M4.91%
2024-03-31$7.68M6.80%
2023-12-31$7.19M-2.02%
2023-09-30$7.34M20.67%
2023-06-30$6.08M-41.42%
2023-03-31$10.38M44.93%
2022-12-31$7.16M206.07%
2022-09-30$2.34M30.73%
2022-06-30$1.79M-87.38%
2022-03-31$14.19M833.29%
2021-12-31$1.52M-84.97%
2021-09-30$10.11M430.92%
2021-06-30$1.91M5.48%
2021-03-31$1.81M16.82%
2020-12-31$1.55M804.09%
2020-09-30$171.00K100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31--

Marinus Pharmaceuticals generated $8.06M in revenue during Q2 2024, up 4.91% compared to the previous quarter, and up 77.61% compared to the same period a year ago.

Marinus Pharmaceuticals Revenue Breakdown

Marinus Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22
Product revenue, net$19.56M$2.87M
Collaboration revenue$54.00K$15.67M

Marinus Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product revenue, net (99.72%), and Collaboration revenue (0.28%).

Quarterly Revenue by Product

Product/ServiceSep 24Jun 24Mar 24Dec 23Jun 23Mar 23Dec 22Sep 22
Collaboration revenue$17.00K$18.00K$18.00K$36.00K$18.00K$3.00M--
Product$8.47M$555.00K------
Product revenue, net-$7.95M$7.51M$11.98M$4.25M$3.33M$2.32M-
Collaboration Revenue-------$12.67M

Marinus Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Product (99.80%), and Collaboration revenue (0.20%).

Marinus Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
OVIDOvid Therapeutics$391.69M$173.00K
AMLXAmylyx Pharmaceuticals$380.79M$416.00K
MIRMMirum Pharmaceuticals$186.37M$77.88M
MRNSMarinus Pharmaceuticals$30.99M$8.06M
IKNAIkena Oncology$9.16M-
CGEMCullinan Oncology--
IMRXImmuneering--
XFORX4 Pharmaceuticals-$560.00K
CABACabaletta Bio--
VKTXViking Therapeutics--
CNTBConnect Biopharma--
ABOSAcumen Pharmaceuticals--
INZYInozyme Pharma--
MDGLMadrigal Pharmaceuticals-$62.17M
ELYMEliem Therapeutics--
TERNTerns Pharmaceuticals--
PMVPPMV Pharmaceuticals--
ETNB89bio--
AKROAkero Therapeutics--
ELVNEnliven Therapeutics--
EWTXEdgewise Therapeutics--

MRNS Revenue FAQ

What is Marinus Pharmaceuticals’s yearly revenue?

Marinus Pharmaceuticals's yearly revenue for 2023 was $30.99M, representing an increase of 21.63% compared to 2022. The company's yearly revenue for 2022 was $25.48M, representing an increase of 66.03% compared to 2021. MRNS's yearly revenue for 2021 was $15.34M, representing an increase of 793.19% compared to 2020.

What is Marinus Pharmaceuticals’s quarterly revenue?

Marinus Pharmaceuticals's quarterly revenue for Q2 2024 was $8.06M, a 4.91% increase from the previous quarter (Q1 2024), and a 32.48% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $7.68M, a 6.80% increase from the previous quarter (Q4 2023), and a -26.02% decrease year-over-year (Q1 2023). MRNS's quarterly revenue for Q4 2023 was $7.19M, a -2.02% decrease from the previous quarter (Q3 2023), and a 0.39% increase year-over-year (Q4 2022).

What is Marinus Pharmaceuticals’s revenue growth rate?

Marinus Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 101.95%, and for the last 5 years (2019-2023) was 0%.

What are Marinus Pharmaceuticals’s revenue streams?

Marinus Pharmaceuticals's revenue streams in c 23 are Product revenue, net, and Collaboration revenue. Product revenue, net generated $19.56M in revenue, accounting 99.72% of the company's total revenue, up 581.09% year-over-year. Collaboration revenue generated $54K in revenue, accounting 0.28% of the company's total revenue, down -99.66% year-over-year.

What is Marinus Pharmaceuticals’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Marinus Pharmaceuticals was Product revenue, net. This segment made a revenue of $19.56M, representing 99.72% of the company's total revenue.